Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8740865 | Journal of Microbiology, Immunology and Infection | 2018 | 6 Pages |
Abstract
Fidaxomicin exhibited high antimicrobial activity against all C. difficile isolates tested, which shows promise as a new drug for treating Chinese CDI patients.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Jing-Wei Cheng, Qi-Wen Yang, Meng Xiao, Shu-Ying Yu, Meng-Lan Zhou, Timothy Kudinha, Fanrong Kong, Jian-Wei Liao, Ying-Chun Xu,